Friday, 4 March 2016

Antibiotics 2017

About Conference


Conference Series LLC invites all the participants from all over the world to attend ‘3rd World Congress and Exhibition on Antibiotics and Antibiotic Resistance' to be held on July 31-August 01, 2017 at Milan, Italy which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
Antibiotics 2017 is a platform to discuss and learn about the latest advancements in the field of Antibiotics and Antibiotic Resistance as the world’s consideration turned regarding the urgency of new antibiotics as the antimicrobial resistance is growing day by day. Many developed nations and International health organizations are trying to focus of the current situation and making new policies to prevent the adverse effects of Antibiotic resistance.
This 2-day conference gathers researchers, academia, labs, Drug Manufacturers, government agencies, health professionals, hospitals, young investigators, pharma and labs and presents their opinions through key notes, and case study presentations. This conference lays a platform for all the researchers working in the field of Antibiotics to know the latest developments and the current situation of the Antibiotic resistance problem.
The global systemic antibiotics market was valued at $39.6 billion in 2013 and is expected to reach $41.2 billion by 2018, at a CAGR of 0.8%. The global market for antifungal therapeutics was valued at $10.7 billion in 2013 and is projected to reach $12.2 billion in 2018, a five-year compound annual growth rate (CAGR) of 2.7%.
Overall sales in the current antibiotics and new products market were nearly $40 billion in 2008. It increased to $41.5 billion in 2009. By 2015, it is projected to increase to $65.5 billion, for a 5-year compound annual growth rate (CAGR) of 9.6%. The largest segment antibiotic drugs market was nearly $36 billion in 2008; this further increased to $37 billion in 2009, this projected to reach $50 billion in 2015, for a 5-year CAGR of 5.9%. Sales in the bacterial vaccines market amounted to $3.6 billion in 2008 which increased slightly to $3.9 billion in 2009. This is projected to increase to $15 billion in 2015, for a 5-year CAGR of 31.6%.
Conference Series LLC organizes 3000+ Global events in conference series every year across  the globe with support from 1000+ more scientific societies and Publishes 1000 Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board members.

Conference Highlights


Special Issues


  •  All accepted abstracts will be published in respective  International Journals.
  •  Abstracts will be provided with Digital Object Identifier by Cross Ref.

See more at: http://antibiotics.pharmaceuticalconferences.com/